Xlife Sciences: Swiss portfolio company Axenoll receives str

Xlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the Eur

Xlife Sciences AG / Key word(s): PatentXlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle 20.01.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) announced today that its Swiss portfolio company Axenoll Life Sciences AG has been granted a stra...

Related Keywords

Zurich , Züsz , Switzerland , Swiss , Oliverr Baumann , Dennis Lennartz , Valentin Handschin , European Patent Office , Xlife Sciences Ag Key , Xlife Sciences , Stock Exchange , Swiss Exchange , Axenoll Life Sciences , European Patent Officetitle , Laxxon Medical , Year Report ,

© 2025 Vimarsana